EP Patent

EP4433445A4 — Compounds, composites and methods for inducing antimicrobial intracellular activity and for preventing and treating microbial infections

Assigned to General Hospital Corp · Expires 2026-04-01 · 0y expired

What this patent protects

Patent listed against Xalkori.

Drugs covered by this patent

Patent Metadata

Patent number
EP4433445A4
Jurisdiction
EP
Classification
—
Expires
2026-04-01
Drug substance claim
No
Drug product claim
No
Assignee
General Hospital Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.